FierceBiotechFierceBioResearcherFierceVaccinesFiercePharma   FierceHealthcare
Syndicate content

Wyeth news from FiercePharma

News

Merck to cut 1,200 sales reps

The axeman cometh to Merck's sales force. The drugmaker plans to lop off about 15 percent in the sales ranks, or 1,200 jobs. The fact that it's not alone in trimming back on reps--Wyeth just Read more...

Enbrel gets black-box infection warning

Enbrel's new black box is now official. Wyeth and Amgen have put the final touches on a Read more...

Wyeth to slash another 1,200 jobs

And the ax is falling again. Wyeth notified employees last Friday than another 1,200 jobs will be slashed from the payroll. That's on top of the Read more...

Lundbeck poaches CEO from Wyeth ranks

Wanted: CEO who can find a new "cash cow" to push a Danish drugmaker past impending patent expirations. Found: Ulf Wiinberg, lately of Wyeth, to take over Lundbeck. Soon to be ex-president Read more...

Wyeth discounts Pristiq for big sales push

Think the latest-and-greatest drug would naturally be the most expensive? Think again. Now that its Pristiq antidepressant is Read more...

SPOTLIGHT: Wyeth sales boosted by Enbrel

Despite major erosion in sales of its heartburn blockbuster Protonix, Wyeth managed to beat Wall Street's expectations for first-quarter earnings, posting a $1.2 billion profit on a 6 percent Read more...
Tags: Protonix   Arthritis   heartburn   Wyeth  

Strategy execs advise Big Pharma

How might drugmakers navigate the rocky waters of generic competition, cautious regulators, safety scandals, globalization, and so on? Seek help with the itinerary from an expert, perhaps. At least Read more...

1,200 Wyeth reps out of work

Don't tell these 1,200 Wyeth sales reps to have a nice weekend. They got pink slips on Wednesday, their jobs eliminated in the drugmaker's Read more...

CFOs are pharma's new power players

Who's pharma's power forward these days? The CFO. Or so concludes Ernst & Young after slicing and dicing two global surveys. As companies shift focus from driving sales growth to managing Read more...
Tags: Wyeth   Pfizer   Merck   Astrazeneca   Amgen   CFO  

BMS chief nabs $10 million raise

Why is Jim Cornelius (photo) smiling? His big promotion to permanent CEO of Bristol-Myers Squibb Read more...
Tags: Wyeth  

Press Releases

PRESS RELEASE: Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies

Raven biotechnologies and Wyeth Pharmaceuticals Extend Evaluation Period of Selected Raven Antibodies SOUTH SAN FRANCISCO, Calif., Dec. 6 -- Raven biotechnologies, inc., a privately held company Read more...

PRESS RELEASE: Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program

Wyeth Consumer Healthcare Initiates Voluntary Recall and Replacement Program for Several Robitussin Products and Children's Dimetapp Cold & Chest Congestion -- Dosage Cup Being Replaced, No Read more...

PRESS RELEASE: Wyeth Jury Awards $99 Million Punitive Damages

Wyeth Jury Awards $99 Million Punitive Damages MADISON, N.J., Oct. 15 -- Wyeth confirmed today that it will appeal the verdict in the Scofield, Rowatt and Forrester v. Wyeth cases in the Second Read more...

PRESS RELEASE: Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms

Study Data Results Showed Desvenlafaxine Significantly Reduced Moderate to Severe Vasomotor Symptoms in Menopausal Women Versus Placebo COLLEGEVILLE, Pa., Oct. 15 -- Wyeth Pharmaceuticals, a Read more...

PRESS RELEASE: Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery

Wyeth Acquires Haptogen to Boost Biotechnology Drug Discovery COLLEGEVILLE, Pa., Oct. 5 -- Wyeth Pharmaceuticals, a division of Wyeth, announced today the signing of a definitive agreement under Read more...